MediWound Ltd. - Ordinary Shares (MDWD)
Healthcare › Medicinal Chemicals & Botanical Products
Price History
Feb 9, 2026 — Mar 31, 2026Investment Snapshot
- P/B of 4.55 — trading above book value
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -54.7%
- Revenue declining 16% annually
MediWound Ltd. - Ordinary Shares (MDWD) is a Healthcare company operating in Medicinal Chemicals & Botanical Products, listed on the NASDAQ , with a market capitalisation of $198 million . Key value metrics: P/B ratio 4.55, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
MediWound Ltd. - Ordinary Shares — Fundamental Analysis Summary
On financial health, MDWD shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -54.7% (sector average: -19.8%), and high leverage with a debt-to-equity ratio of 2.33.
StockPik's composite Value Score for MDWD is 35/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MDWD reports a thin gross margin of 19.2% (sector average: 33.5%) and a negative operating margin of -149.0%.
MDWD shows revenue declining at 16% year-over-year, with earnings growing at 21%.